Skip to content
In temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved
Source link
Tags: C&E Industry News Filter, Cancer, Cancer Drugs, chemotherapy, Chemotherapy/Radiotherapy/Immunotherapy, Content Types, corporate, Corporate/Industrial News, Factiva Filters, general news, government policy, Health, healthcare, Healthcare/Life Sciences, immunotherapy, industrial news, life sciences, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, new products, New Products/Services, output, Output/Production, Pharmaceuticals, political, Political/General News, procedures, product, Product Shortage, Product/Service Approvals, production, products, Products/Services, radiotherapy, regulation, Regulation/Government Policy, service approvals, services, specialized drugs, Specialized Drugs/Medications, SYND, WSJ-PRO-WSJ.com, wsjhealth
